Pharmaceutical Innovation: Europe’s Challenge Amid Decline
Pharmaceutical innovation is at a crucial juncture, with industry leaders expressing concern over the shifting dynamics of medicine development.According to Pascal Soriot, CEO of AstraZeneca, Europe’s standing in the pharmaceutical landscape is in jeopardy, particularly as investments pivot toward the US pharmaceutical market.










